These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8458418)
1. Peptide aldehydes as inhibitors of HIV protease. Sarubbi E; Seneci PF; Angelastro MR; Peet NP; Denaro M; Islam K FEBS Lett; 1993 Mar; 319(3):253-6. PubMed ID: 8458418 [TBL] [Abstract][Full Text] [Related]
2. Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease. Kempf DJ Methods Enzymol; 1994; 241():334-54. PubMed ID: 7854187 [No Abstract] [Full Text] [Related]
3. Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease. Yedidi RS; Muhuhi JM; Liu Z; Bencze KZ; Koupparis K; O'Connor CE; Kovari IA; Spaller MR; Kovari LC Biochem Biophys Res Commun; 2013 Sep; 438(4):703-8. PubMed ID: 23921229 [TBL] [Abstract][Full Text] [Related]
4. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic. Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353 [TBL] [Abstract][Full Text] [Related]
5. Model peptides to study the effects of P2 and P3 substitutions in statine-containing HIV proteinase inhibitors. Hui KY; Hermann RB; Manetta JV; Gygi T; Angleton EL FEBS Lett; 1993 Aug; 327(3):355-60. PubMed ID: 8348964 [TBL] [Abstract][Full Text] [Related]
6. Studies of HIV-1 protease inhibitors. I. Incorporation of a reduced peptide, simple aminoalcohol, and statine analog at the scissile site of substrate sequences. Sakurai M; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1369-77. PubMed ID: 8403085 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic. Kiso Y Adv Exp Med Biol; 1995; 362():413-23. PubMed ID: 8540352 [No Abstract] [Full Text] [Related]
9. A modular approach to HIV-1 proteinase inhibitor design. Uhlíková T; Konvalinka J; Pichová I; Soucek M; Kräusslich HG; Vondrásek J Biochem Biophys Res Commun; 1996 May; 222(1):38-43. PubMed ID: 8630071 [TBL] [Abstract][Full Text] [Related]
10. The inhibition of HIV-1 protease by interface peptides. Schramm HJ; Billich A; Jaeger E; Rücknagel KP; Arnold G; Schramm W Biochem Biophys Res Commun; 1993 Jul; 194(2):595-600. PubMed ID: 8343146 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors. Use of L-mannaric acid as a peptidomimetic scaffold. Alterman M; Björsne M; Mühlman A; Classon B; Kvarnström I; Danielson H; Markgren PO; Nillroth U; Unge T; Hallberg A; Samuelsson B J Med Chem; 1998 Sep; 41(20):3782-92. PubMed ID: 9748353 [TBL] [Abstract][Full Text] [Related]
12. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties. Frecer V; Berti F; Benedetti F; Miertus S J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515 [TBL] [Abstract][Full Text] [Related]
13. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development. Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781 [TBL] [Abstract][Full Text] [Related]
14. Comparison of inhibitor binding to feline and human immunodeficiency virus proteases: structure-based drug design and the resistance problem. Dunn BM; Pennington MW; Frase DC; Nash K Biopolymers; 1999; 51(1):69-77. PubMed ID: 10380354 [TBL] [Abstract][Full Text] [Related]
15. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease. Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829 [TBL] [Abstract][Full Text] [Related]
16. Crucial amides for dimerization inhibitors of HIV-1 protease. Bowman MJ; Chmielewski J Bioorg Med Chem Lett; 2004 Mar; 14(6):1395-8. PubMed ID: 15006369 [TBL] [Abstract][Full Text] [Related]
17. Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands. Ghosh AK; Takayama J; Kassekert LA; Ella-Menye JR; Yashchuk S; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H Bioorg Med Chem Lett; 2015 Nov; 25(21):4903-4909. PubMed ID: 26096678 [TBL] [Abstract][Full Text] [Related]